Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16)

Journal of Medical Screening

Volumn 14, Issue 4, 2007, Pages 191-199

  Chen, Li Sheng ^a,b   Liao, Chao Sheng ^c   Chang, Shu Hui ^a   Lai, Hsin Chih ^a   Chen, Tony Hsiu Hsi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FEMALE; HEALTH CARE POLICY; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; RECEIVER OPERATING CHARACTERISTIC;

AGED; AGED, 80 AND OVER; ALGORITHMS; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; POPULATION; REFERENCE VALUES; ROC CURVE;

EID: 36849036302     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/096914107782912022     Document Type: Article

References (14)

1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71
2. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7
3. Kronborg O, Fenger C, Olsen J, et al. Randomized study as of screening for colorectal cancer with faecal occult blood test. Lancet 1996;348:1467-71
4. Ahlquist D, Wieand H, Moertal C, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and Hemoquant. JAMA 1993;269:1262-7
5. Zappa M, Castiglione G, Paci E, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer 2001;92:151-4
6. Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res 1996;87:1011-24
7. Chen THH, Chiu YH, Luh DL, et al. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Taiwan Community-based Integrated Community Screening Group. Cancer 2004;100:1734-43
8. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomized trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-22
9. Yang KC, Liao CS, Chiu YH, Yen AMF, Chen THH. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. J Med Screen 2006;13:S8-13
10. Greenberg PD, Bertario L, Gnauck R, et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000;95:1331-8
11. Saito H. Sensitivity of immunochemical occult blood testing in detecting early colorectal cancer. Nippon Rinsho 1996;54:1421-4
12. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155-9
13. Nakama H, Zhang B, Zhang Y. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer 2001;37:398-401
14. Wong WM, Lam SK, Cheung KL, et al. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer 2003;97:2420-4